Catalent Inc
NYSE:CTLT
Catalent Inc
Free Cash Flow
Catalent Inc
Free Cash Flow Peer Comparison
Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors
Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Catalent Inc
NYSE:CTLT
|
Free Cash Flow
-$263m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Free Cash Flow
$18.2B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Free Cash Flow
$12.7B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
20%
|
CAGR 10-Years
15%
|
|
Pfizer Inc
NYSE:PFE
|
Free Cash Flow
$4.8B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-11%
|
|
Merck & Co Inc
NYSE:MRK
|
Free Cash Flow
$9.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-1%
|
|
Eli Lilly and Co
NYSE:LLY
|
Free Cash Flow
-$3.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Catalent Inc's Free Cash Flow?
Free Cash Flow
-263m
USD
Based on the financial report for Dec 31, 2023, Catalent Inc's Free Cash Flow amounts to -263m USD.
What is Catalent Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 3Y
-25%
Over the last year, the Free Cash Flow growth was 29%. The average annual Free Cash Flow growth rates for Catalent Inc have been -25% over the past three years .